BEST VITELLIFORM MACULAR DYSTROPHY

Clinical trials for BEST VITELLIFORM MACULAR DYSTROPHY explained in plain language.

Never miss a new study

Get alerted when new BEST VITELLIFORM MACULAR DYSTROPHY trials appear

Sign up with your email to follow new studies for BEST VITELLIFORM MACULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

One-Shot gene injection tested for rare blinding eye conditions

Disease control Recruiting now

This early-stage study is testing a one-time gene therapy injection called OPGx-BEST1 for two rare, inherited eye diseases (BVMD and ARB) that cause vision loss. The main goal is to check the safety and side effects of the treatment and find the best dose. Researchers will follow…

Matched conditions: BEST VITELLIFORM MACULAR DYSTROPHY

Phase: PHASE1, PHASE2 • Sponsor: Opus Genetics, Inc • Aim: Disease control

Last updated Mar 27, 2026 12:41 UTC

BEST VITELLIFORM MACULAR DYSTROPHY

Get alerted when new BEST VITELLIFORM MACULAR DYSTROPHY trials appear

One-Shot gene injection tested for rare blinding eye conditions